Javascript must be enabled to continue!
Effects of different doses of remimazolam on the quality of sedation and cardiac function in elderly patients: a double-blind randomised controlled study
View through CrossRef
BackgroundWe intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.MethodsA total of 135 ASA I–III patients undergoing elective laparoscopic cholecystectomy were selected. They were divided into three groups and they were randomized. Low dose group (Group L): Remimazolam besylate 0.2 mg/kg; middle dose group (Group M): Remimazolam besylate 0.3 mg/kg; High dose group (Group H): Remimazolam besylate 0.4 mg/kg. There were 45 patients in each group. The blood pressure, heart rate, BIS values, cardiac function before induction (T0), after induction (T1) and after intubation (T2), as well as the length of loss of consciousness, duration of sedation, and extubation and adverse events were recorded.ResultsAt T1 and T2, systolic and diastolic blood pressure in Group M were lower than those in Group L, but higher than those in Group H, with statistically significant differences (P < 0.05). At T1 and T2, the BIS value in Group M was lower than that in Group L, with a statistically significant difference (P < 0.05). However, there was no statistically significant difference (P > 0.05) in BIS values between Group M and Group H; At T1 and T2, the cardiac output and stroke volume in Group M were higher than those in Group H, while the systemic vascular resistance in Group M was lower than that in Group H, with statistically significant differences (P < 0.05); The incidences of bucking when moving and hiccup in Group L were higher than those in Group M and Group H, with statistically significant differences (P < 0.05). The number of vasoactive drugs used in Group H was higher than that in Group L and Group M, with statistically significant differences (P < 0.05).ConclusionsGeneral anesthesia induction with remimazolam besylate at 0.3 mg/kg in elderly patients undergoing laparoscopic cholecystectomy showed good quality of sedation, could achieve rapid intubation, with minimal effect on cardiac function and generally favorable safety profile.
Frontiers Media SA
Title: Effects of different doses of remimazolam on the quality of sedation and cardiac function in elderly patients: a double-blind randomised controlled study
Description:
BackgroundWe intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.
MethodsA total of 135 ASA I–III patients undergoing elective laparoscopic cholecystectomy were selected.
They were divided into three groups and they were randomized.
Low dose group (Group L): Remimazolam besylate 0.
2 mg/kg; middle dose group (Group M): Remimazolam besylate 0.
3 mg/kg; High dose group (Group H): Remimazolam besylate 0.
4 mg/kg.
There were 45 patients in each group.
The blood pressure, heart rate, BIS values, cardiac function before induction (T0), after induction (T1) and after intubation (T2), as well as the length of loss of consciousness, duration of sedation, and extubation and adverse events were recorded.
ResultsAt T1 and T2, systolic and diastolic blood pressure in Group M were lower than those in Group L, but higher than those in Group H, with statistically significant differences (P < 0.
05).
At T1 and T2, the BIS value in Group M was lower than that in Group L, with a statistically significant difference (P < 0.
05).
However, there was no statistically significant difference (P > 0.
05) in BIS values between Group M and Group H; At T1 and T2, the cardiac output and stroke volume in Group M were higher than those in Group H, while the systemic vascular resistance in Group M was lower than that in Group H, with statistically significant differences (P < 0.
05); The incidences of bucking when moving and hiccup in Group L were higher than those in Group M and Group H, with statistically significant differences (P < 0.
05).
The number of vasoactive drugs used in Group H was higher than that in Group L and Group M, with statistically significant differences (P < 0.
05).
ConclusionsGeneral anesthesia induction with remimazolam besylate at 0.
3 mg/kg in elderly patients undergoing laparoscopic cholecystectomy showed good quality of sedation, could achieve rapid intubation, with minimal effect on cardiac function and generally favorable safety profile.
Related Results
Inhaled Remimazolam Potentiates Inhaled Remifentanil in Rodents
Inhaled Remimazolam Potentiates Inhaled Remifentanil in Rodents
BACKGROUND:
Remimazolam is an ester-based short-acting benzodiazepine currently in clinical trials for IV administration. This study explored the feasibility of...
Safety of remimazolam in comparison with midazolam for colonoscopy: A systematic review and meta-analysis
Safety of remimazolam in comparison with midazolam for colonoscopy: A systematic review and meta-analysis
Background Remimazolam is an ester-based ultra-short-acting benzodiazepine that efficiently achieves sedation within a short period and is now being assessed as a suitable alternat...
Does the Sensitivity of Intravenous Anesthetic of Remimazolam Increase in Patients With Obstructive Jaundice?
Does the Sensitivity of Intravenous Anesthetic of Remimazolam Increase in Patients With Obstructive Jaundice?
Abstract
BackgroundIt is well known that obstructive jaundice could affect the pharmacodynamics of some anesthetics, and the sensitivity of some anesthetics would increase ...
Remimazolam Versus Propofol for General Anesthesia in Older Adults Undergoing Colon Cancer Surgery: A Systematic Review and Meta-Analysis of Comparative Studies
Remimazolam Versus Propofol for General Anesthesia in Older Adults Undergoing Colon Cancer Surgery: A Systematic Review and Meta-Analysis of Comparative Studies
Background: Propofol is widely used for anesthesia in colorectal cancer surgery, but is frequently associated with hypotension and respiratory depression. Remimazolam, a novel ultr...
Real‐World Evaluation of Remimazolam for Sedation During Gastrointestinal Endoscopy: Efficacy, Safety, and Risk Factors
Real‐World Evaluation of Remimazolam for Sedation During Gastrointestinal Endoscopy: Efficacy, Safety, and Risk Factors
ABSTRACT
Background and Aim
Remimazolam is a benzodiazepine receptor agonist intravenous anesthetic. This study aimed to ...
Safety of endoscopist-guided sedation in a low-risk collective
Safety of endoscopist-guided sedation in a low-risk collective
Abstract
Introduction Worldwide, gastrointestinal endoscopies are predominantly performed under sedation. National and international guidelines and recommendations contai...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Anesthetic Management Using Remimazolam in a Hemodialysis Patient
Anesthetic Management Using Remimazolam in a Hemodialysis Patient
Remimazolam, an ultra-short-acting benzodiazepine, is a new intravenous anesthetic used for sedation and general anesthesia. Because remimazolam is primarily metabolized by carboxy...

